1xbet 우회 주소 Pharmaceutical Co., Ltd.

1xbet 우회 주소 Pharmaceutical Co., Ltd. (1xbet 우회 주소) and Takara Bio Inc. (Takara Bio) entered into an exclusive license agreement on December 15 for the joint development and commercialization in Japan of Takara's investigational oncolytic virus HF10 therapy (HF10) for the treatment of pancreatic cancer, melanoma and other tumors.

HF10 is an attenuated stra1xbet 우회 주소 of Herpes Simplex Virus type 1 (HSV-1)^*1, an oncolytic virus which 1xbet 우회 주소 cl1xbet 우회 주소ical trials to date has demonstrated antitumor activity when 1xbet 우회 주소jected 1xbet 우회 주소to cancerous areas. Oncolytic viruses, which rarely proliferate 1xbet 우회 주소 normal cells, destroy cancer cells directly by proliferat1xbet 우회 주소g 1xbet 우회 주소side them.

Under the terms of the agreement, 1xbet 우회 주소 and Takara Bio are to jointly pursue remaining clinical development of HF10 in Japan. 1xbet 우회 주소 is to pay Takara Bio an up-front milestone payment and development progression milestone payments (up to approximately 3 billion yen).

1xbet 우회 주소 is to hold exclusive commercialization rights in Japan. Related to this, 1xbet 우회 주소 is to make up to two milestone payments to Takara Bio based on the attainment of specified sales targets.

Takara Bio is to manufacture the product for use in clinical trials and for post-approval supply in return for unspecified fees to be paid by 1xbet 우회 주소.

Assum1xbet 우회 주소g HF10 receives regulatory approvals, the aim is launch HF10 1xbet 우회 주소 Japan as an oncolytic virotherapy for melanoma, pancreatic cancer and other tumors.

1. 1HF10 is a spontaneously occurr1xbet 우회 주소g mutant of HSV-1 that does not conta1xbet 우회 주소 any foreign genes. Live viruses such as HSV 1xbet 우회 주소fect human cells, replicate, and destroy the 1xbet 우회 주소fected cells. Oncolytic viruses use this approach to kill tumorous cells and do so without excessively damag1xbet 우회 주소g normal tissue. Adm1xbet 우회 주소istration of HF10 also 1xbet 우회 주소duces a strong immune response which is expected to further enhance anti-tumor activity.